These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 26650730)

  • 41. Percutaneous epicardial access for mapping and ablation is feasible in patients with prior cardiac surgery, including coronary bypass surgery.
    Killu AM; Ebrille E; Asirvatham SJ; Munger TM; McLeod CJ; Packer DL; Friedman PA; Mulpuru SK
    Circ Arrhythm Electrophysiol; 2015 Feb; 8(1):94-101. PubMed ID: 25575533
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diagnosis, significance, and management of ventricular thrombi in patients referred for VT ablation.
    Beavers DL; Ghannam M; Liang J; Cochet H; Attili A; Sharaf-Dabbagh G; Latchamsetty R; Jongnarangsin K; Morady F; Bogun F
    J Cardiovasc Electrophysiol; 2021 Sep; 32(9):2473-2483. PubMed ID: 34270148
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Management and outcomes of cardiac tamponade during atrial fibrillation ablation in the presence of therapeutic anticoagulation with warfarin.
    Latchamsetty R; Gautam S; Bhakta D; Chugh A; John RM; Epstein LM; Miller JM; Michaud GF; Oral H; Morady F; Jongnarangsin K
    Heart Rhythm; 2011 Jun; 8(6):805-8. PubMed ID: 21236362
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bundled preparation of skin antisepsis decreases the risk of cardiac implantable electronic device-related infection.
    Chen HC; Chen MC; Chen YL; Tsai TH; Pan KL; Lin YS
    Europace; 2016 Jun; 18(6):858-67. PubMed ID: 26056185
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Frequency and sequelae of retained implanted cardiac device material post heart transplantation.
    Martin A; Voss J; Shannon D; Ruygrok P; Lever N
    Pacing Clin Electrophysiol; 2014 Feb; 37(2):242-8. PubMed ID: 24428516
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Feasibility and safety of uninterrupted rivaroxaban for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: results from a multicenter prospective registry.
    Lakkireddy D; Reddy YM; Di Biase L; Vallakati A; Mansour MC; Santangeli P; Gangireddy S; Swarup V; Chalhoub F; Atkins D; Bommana S; Verma A; Sanchez JE; Burkhardt JD; Barrett CD; Baheiry S; Ruskin J; Reddy V; Natale A
    J Am Coll Cardiol; 2014 Mar; 63(10):982-8. PubMed ID: 24412445
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Periprocedural anticoagulation of patients undergoing pericardiocentesis for cardiac tamponade complicating catheter ablation of atrial fibrillation.
    Lin T; Bai R; Chen YW; Yu RH; Tang RB; Sang CH; Li SN; Ma CS; Dong JZ
    Int Heart J; 2015; 56(1):56-61. PubMed ID: 25503659
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Biventricular defibrillator patients have higher complication rates after revision of recalled leads.
    Brumberg GE; Kaseer B; Shah H; Saba S; Jain S
    Pacing Clin Electrophysiol; 2012 Jun; 35(6):665-71. PubMed ID: 22519559
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Periprocedural stroke and bleeding complications in patients undergoing catheter ablation of atrial fibrillation with different anticoagulation management: results from the Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation (COMPARE) randomized trial.
    Di Biase L; Burkhardt JD; Santangeli P; Mohanty P; Sanchez JE; Horton R; Gallinghouse GJ; Themistoclakis S; Rossillo A; Lakkireddy D; Reddy M; Hao S; Hongo R; Beheiry S; Zagrodzky J; Rong B; Mohanty S; Elayi CS; Forleo G; Pelargonio G; Narducci ML; Dello Russo A; Casella M; Fassini G; Tondo C; Schweikert RA; Natale A
    Circulation; 2014 Jun; 129(25):2638-44. PubMed ID: 24744272
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Retained cardiac implantable electronic device fragments are not associated with magnetic resonance imaging safety issues, morbidity, or mortality after orthotopic heart transplant.
    Austin CO; Landolfo K; Parikh PP; Patel PC; Venkatachalam KL; Kusumoto FM
    Am Heart J; 2017 Aug; 190():46-53. PubMed ID: 28760213
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Feasibility and clinical efficacy of left atrial ablation for the treatment of atrial tachyarrhythmias in patients with left atrial appendage closure devices.
    Heeger CH; Rillig A; Lin T; Mathew S; Deiss S; Lemes C; Botros M; Metzner A; Wissner E; Kuck KH; Ouyang F; Tilz RR
    Heart Rhythm; 2015 Jul; 12(7):1524-31. PubMed ID: 25769512
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Endovenous laser therapy and radiofrequency ablation of the great saphenous vein: analysis of early efficacy and complications.
    Puggioni A; Kalra M; Carmo M; Mozes G; Gloviczki P
    J Vasc Surg; 2005 Sep; 42(3):488-93. PubMed ID: 16171593
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical significance of atrial fibrillation detected by cardiac implantable electronic devices.
    DeCicco AE; Finkel JB; Greenspon AJ; Frisch DR
    Heart Rhythm; 2014 Apr; 11(4):719-24. PubMed ID: 24394157
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Novel oral anticoagulants in a real-world cohort of patients undergoing catheter ablation of atrial fibrillation.
    Eitel C; Koch J; Sommer P; John S; Kircher S; Bollmann A; Arya A; Piorkowski C; Hindricks G
    Europace; 2013 Nov; 15(11):1587-93. PubMed ID: 23703362
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An analysis of pump thrombus events in patients in the HeartWare ADVANCE bridge to transplant and continued access protocol trial.
    Najjar SS; Slaughter MS; Pagani FD; Starling RC; McGee EC; Eckman P; Tatooles AJ; Moazami N; Kormos RL; Hathaway DR; Najarian KB; Bhat G; Aaronson KD; Boyce SW;
    J Heart Lung Transplant; 2014 Jan; 33(1):23-34. PubMed ID: 24418731
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ventricular Tachycardia Ablation in the Presence of Left Ventricular Thrombus: Safety and Efficacy.
    Rao HB; Yu R; Chitnis N; DO D; Boyle NG; Shivkumar K; Bradfield JS
    J Cardiovasc Electrophysiol; 2016 Apr; 27(4):453-9. PubMed ID: 26643285
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cardiac implantable electronic device lead extraction in patients with underlying infection using open thoracotomy or percutaneous techniques.
    Patel D; Khan F; Shah H; Bhattacharya S; Adelstein E; Saba S
    Cardiol J; 2015; 22(1):68-74. PubMed ID: 24846514
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Utility and safety of temporary pacing using active fixation leads and externalized re-usable permanent pacemakers after lead extraction.
    Kawata H; Pretorius V; Phan H; Mulpuru S; Gadiyaram V; Patel J; Steltzner D; Krummen D; Feld G; Birgersdotter-Green U
    Europace; 2013 Sep; 15(9):1287-91. PubMed ID: 23482613
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sudden Death in Patients With Cardiac Implantable Electronic Devices.
    Tseng ZH; Hayward RM; Clark NM; Mulvanny CG; Colburn BJ; Ursell PC; Olgin JE; Hart AP; Moffatt E
    JAMA Intern Med; 2015 Aug; 175(8):1342-50. PubMed ID: 26098676
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Radiofrequency and Cryo-Ablation Effect on Transvenous Pacing and Defibrillatory Lead Integrity: An In Vitro Study.
    Darrat YH; Agarwal A; Morales GX; Thompson J; Abdel-Latif A; Waespe K; DI Biase L; Natale A; Patwardan A; Elayi CS
    J Cardiovasc Electrophysiol; 2016 Aug; 27(8):976-80. PubMed ID: 27138905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.